| Dr John Lauren Remington, MD | |
|
1025 Medical Center Dr, Wilmington, NC 28401 | |
| (910) 763-1800 | |
| (910) 763-6419 |
| Full Name | Dr John Lauren Remington |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 45 Years |
| Location | 1025 Medical Center Dr, Wilmington, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629075189 | NPI | - | NPPES |
| 8901898 | Medicaid | NC | |
| 26976 | Other | NC | MEDICAL LICENSE |
| 7901897 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 26976 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New Hanover Regional Medical Center | Wilmington, NC | Hospital |
| Novant Health Brunswick Medical Center | Supply, NC | Hospital |
| J Arthur Dosher Memorial Hospital | Southport, NC | Hospital |
| Pender Memorial Hospital | Burgaw, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Delaney Radiologists Group Pllc | 4981684875 | 47 |
| Wilmington Health Pllc | 6103722509 | 283 |
| Delaney Radiologists Pa | 6305813684 | 47 |
News Archive
Long term use of incense increases the risk of developing cancers of the respiratory tract, according to a new study. The new analysis, which the authors say is the first prospective investigation of incense and cancer risk, appears in the October 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
"President Barack Obama outlined an ambitious agenda in his State of the Union address Tuesday that included raising the minimum wage, increasing spending on infrastructure, attacking climate change and passing gun-control legislation," the Wall Street Journal reports.
Men with localized prostate cancer are faced with deciding among a range of options for treatment - including a choice between robot-assisted versus conventional prostatectomy.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that the results of the M118 EMINENCE clinical trial have published in Circulation.
› Verified 4 days ago
| Entity Name | Wilmington Health Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881632339 PECOS PAC ID: 6103722509 Enrollment ID: O20031208000800 |
News Archive
Long term use of incense increases the risk of developing cancers of the respiratory tract, according to a new study. The new analysis, which the authors say is the first prospective investigation of incense and cancer risk, appears in the October 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
"President Barack Obama outlined an ambitious agenda in his State of the Union address Tuesday that included raising the minimum wage, increasing spending on infrastructure, attacking climate change and passing gun-control legislation," the Wall Street Journal reports.
Men with localized prostate cancer are faced with deciding among a range of options for treatment - including a choice between robot-assisted versus conventional prostatectomy.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that the results of the M118 EMINENCE clinical trial have published in Circulation.
› Verified 4 days ago
| Entity Name | Delaney Radiologists Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912982166 PECOS PAC ID: 4981684875 Enrollment ID: O20040721001496 |
News Archive
Long term use of incense increases the risk of developing cancers of the respiratory tract, according to a new study. The new analysis, which the authors say is the first prospective investigation of incense and cancer risk, appears in the October 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
"President Barack Obama outlined an ambitious agenda in his State of the Union address Tuesday that included raising the minimum wage, increasing spending on infrastructure, attacking climate change and passing gun-control legislation," the Wall Street Journal reports.
Men with localized prostate cancer are faced with deciding among a range of options for treatment - including a choice between robot-assisted versus conventional prostatectomy.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that the results of the M118 EMINENCE clinical trial have published in Circulation.
› Verified 4 days ago
| Entity Name | Delaney Radiologists Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902881147 PECOS PAC ID: 6305813684 Enrollment ID: O20040915000814 |
News Archive
Long term use of incense increases the risk of developing cancers of the respiratory tract, according to a new study. The new analysis, which the authors say is the first prospective investigation of incense and cancer risk, appears in the October 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
"President Barack Obama outlined an ambitious agenda in his State of the Union address Tuesday that included raising the minimum wage, increasing spending on infrastructure, attacking climate change and passing gun-control legislation," the Wall Street Journal reports.
Men with localized prostate cancer are faced with deciding among a range of options for treatment - including a choice between robot-assisted versus conventional prostatectomy.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that the results of the M118 EMINENCE clinical trial have published in Circulation.
› Verified 4 days ago
| Entity Name | Diagnostic Imaging Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679025522 PECOS PAC ID: 8820374069 Enrollment ID: O20170424001606 |
News Archive
Long term use of incense increases the risk of developing cancers of the respiratory tract, according to a new study. The new analysis, which the authors say is the first prospective investigation of incense and cancer risk, appears in the October 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
"President Barack Obama outlined an ambitious agenda in his State of the Union address Tuesday that included raising the minimum wage, increasing spending on infrastructure, attacking climate change and passing gun-control legislation," the Wall Street Journal reports.
Men with localized prostate cancer are faced with deciding among a range of options for treatment - including a choice between robot-assisted versus conventional prostatectomy.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that the results of the M118 EMINENCE clinical trial have published in Circulation.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Lauren Remington, MD 1025 Medical Center Drive, Wilmington, NC 28401-6011 Ph: (910) 763-1800 | Dr John Lauren Remington, MD 1025 Medical Center Dr, Wilmington, NC 28401 Ph: (910) 763-1800 |
News Archive
Long term use of incense increases the risk of developing cancers of the respiratory tract, according to a new study. The new analysis, which the authors say is the first prospective investigation of incense and cancer risk, appears in the October 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
"President Barack Obama outlined an ambitious agenda in his State of the Union address Tuesday that included raising the minimum wage, increasing spending on infrastructure, attacking climate change and passing gun-control legislation," the Wall Street Journal reports.
Men with localized prostate cancer are faced with deciding among a range of options for treatment - including a choice between robot-assisted versus conventional prostatectomy.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that the results of the M118 EMINENCE clinical trial have published in Circulation.
› Verified 4 days ago
Dr. Aaron D Kline, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1025 Medical Center Dr, Wilmington, NC 28401 Phone: 910-762-3882 | |
Dr. Andrew James Adamson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1025 Medical Center Dr, Wilmington, NC 28401 Phone: 910-762-3882 Fax: 910-763-6419 | |
Dr. Charles Rogers Neal, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1988 S 16th St, Wilmington, NC 28401 Phone: 910-251-1839 Fax: 910-251-8286 | |
Matthew Gregory Wrench, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1025 Medical Center Dr, Wilmington, NC 28401 Phone: 910-762-3882 | |
Dr. Sandip Jayant Patel, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Delaney Radiologists Group, Pllc, 1025 Medical Center Dr, Wilmington, NC 28401 Phone: 910-763-1800 Fax: 910-763-6419 | |
Dr. Thomas Scott Dziedzic, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1025 Medical Center Dr, Wilmington, NC 28401 Phone: 910-762-3882 | |
Dr. Larry Neal Beard Jr., M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1025 Medical Center Dr, Wilmington, NC 28401 Phone: 910-763-1800 Fax: 910-763-6419 |